Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-02

FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for FANAPT (iloperidone) submitted by Vanda Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fanapt (iloperidone)

Snippet

SUPPL AP for FANAPT (ILOPERIDONE)